Kingsview Wealth Management’s Johnson & Johnson JNJ Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2026
Q1 | $24.2M | Sell |
98,946
-7,901
| -7% | -$1.84M | 0.33% | 53 |
|
|
2025
Q4 | $22.1M | Sell |
106,847
-12,517
| -10% | -$2.48M | 0.32% | 56 |
|
|
2025
Q3 | $22.1M | Buy |
119,364
+23,479
| +24% | +$4.02M | 0.34% | 51 |
|
|
2025
Q2 | $14.6M | Buy |
95,885
+19,909
| +26% | +$3.06M | 0.25% | 70 |
|
|
2025
Q1 | $12.6M | Sell |
75,976
-66,389
| -47% | -$10.4M | 0.24% | 77 |
|
|
2024
Q4 | $20.6M | Sell |
142,365
-9,891
| -6% | -$1.53M | 0.4% | 43 |
|
|
2024
Q3 | $24.7M | Buy |
152,256
+5,306
| +4% | +$845K | 0.52% | 41 |
|
|
2024
Q2 | $21.5M | Buy |
146,950
+9,008
| +7% | +$1.34M | 0.51% | 36 |
|
|
2024
Q1 | $21.8M | Buy |
137,942
+1,559
| +1% | +$248K | 0.55% | 35 |
|
|
2023
Q4 | $21.4M | Buy |
136,383
+31,982
| +31% | +$4.9M | 0.64% | 31 |
|
|
2023
Q3 | $16.3M | Sell |
104,401
-6,043
| -5% | -$997K | 0.58% | 29 |
|
|
2023
Q2 | $18.3M | Buy |
110,444
+1,026
| +0.9% | +$166K | 0.72% | 24 |
|
|
2023
Q1 | $17M | Sell |
109,418
-6,500
| -6% | -$1.05M | 0.71% | 22 |
|
|
2022
Q4 | $20.5M | Sell |
115,918
-16,987
| -13% | -$2.93M | 0.89% | 19 |
|
|
2022
Q3 | $21.7M | Buy |
132,905
+9,628
| +8% | +$1.63M | 1.03% | 11 |
|
|
2022
Q2 | $21.9M | Buy |
123,277
+17,710
| +17% | +$3.16M | 1.05% | 10 |
|
|
2022
Q1 | $18.7M | Buy |
105,567
+1,826
| +2% | +$311K | 0.82% | 16 |
|
|
2021
Q4 | $17.7M | Buy |
103,741
+1,512
| +1% | +$248K | 0.74% | 19 |
|
|
2021
Q3 | $16.5M | Buy |
102,229
+6,202
| +6% | +$1.06M | 0.78% | 21 |
|
|
2021
Q2 | $15.9M | Buy |
96,027
+3,532
| +4% | +$585K | 0.79% | 21 |
|
|
2021
Q1 | $15.1M | Buy |
92,495
+3,304
| +4% | +$535K | 0.86% | 15 |
|
|
2020
Q4 | $14M | Buy |
89,191
+3,904
| +5% | +$576K | 1.02% | 13 |
|
|
2020
Q3 | $12.7M | Buy |
85,287
+305
| +0.4% | +$45.1K | 1.14% | 9 |
|
|
2020
Q2 | $12M | Buy |
84,982
+4,172
| +5% | +$608K | 1.2% | 9 |
|
|
2020
Q1 | $10.6M | Buy |
80,810
+18,223
| +29% | +$2.59M | 1.43% | 6 |
|
|
2019
Q4 | $9.13M | Buy |
62,587
+4,430
| +8% | +$601K | 1.14% | 9 |
|
|
2019
Q3 | $7.52M | Buy |
58,157
+1,724
| +3% | +$227K | 1.18% | 9 |
|
|
2019
Q2 | $7.86M | Buy |
56,433
+7,061
| +14% | +$977K | 1.32% | 9 |
|
|
2019
Q1 | $6.9M | Buy |
49,372
+4,199
| +9% | +$562K | 1.05% | 14 |
|
|
2018
Q4 | $5.83M | Buy |
45,173
+2,935
| +7% | +$409K | 1.27% | 10 |
|
|
2018
Q3 | $5.84M | Buy |
42,238
+596
| +1% | +$79.2K | 1.18% | 9 |
|
|
2018
Q2 | $5.05M | Sell |
41,642
-1,370
| -3% | -$171K | 1.21% | 9 |
|
|
2018
Q1 | $5.51M | Buy |
43,012
+23,302
| +118% | +$3.15M | 1.37% | 9 |
|
|
2017
Q4 | $2.75M | Buy |
19,710
+3,929
| +25% | +$547K | 0.98% | 18 |
|
|
2017
Q3 | $2.05M | Buy |
15,781
+2,580
| +20% | +$342K | 0.9% | 23 |
|
|
2017
Q2 | $1.75M | Buy |
13,201
+795
| +6% | +$101K | 0.9% | 27 |
|
|
2017
Q1 | $1.54M | Buy |
+12,406
| New | +$1.48M | 0.92% | 18 |
|
Other funds holding JNJ
VCM
VPM
Kingsview Wealth Management's JNJ Position: Q1 2026 in Review
Kingsview Wealth Management reduced its Johnson & Johnson (JNJ) stake by 7.4% in Q1 2026, selling an estimated $1.84M and leaving 98,946 shares worth $24.2M. The position accounts for 0.33% of the portfolio, ranked #53.
Kingsview Wealth Management first reported a position in JNJ in Q1 2017 and has held it in 37 quarters since. The position peaked at $24.7M in Q3 2024. 4,615 funds tracked by Wall St. Rank hold JNJ as of Q1 2026.
- Kingsview Wealth Management held 98,946 shares of Johnson & Johnson worth $24.2M as of Q1 2026.
- Kingsview Wealth Management sold 7,901 Johnson & Johnson shares in Q1 2026, an estimated $1.84M.
- Johnson & Johnson made up 0.33% of Kingsview Wealth Management's portfolio in Q1 2026, its #53 holding.
- Kingsview Wealth Management first reported a position in Johnson & Johnson in Q1 2017 and has held it in 37 quarters since.
- Kingsview Wealth Management's Johnson & Johnson position peaked at $24.7M in Q3 2024.
- 4,615 funds tracked by Wall St. Rank held Johnson & Johnson as of Q1 2026.
Based on Kingsview Wealth Management's 13F filing for Q1 2026, filed 12 May 2026.